Erratum: MiR-181b-5p Downregulates NOVA1 to Suppress Proliferation, Migration and Invasion and Promote Apoptosis in Astrocytoma (PLoS ONE (2014) 9: 10 (e109124) DOI: 10.1371/journal.pone.0109124);MiR-181b-5p downregulates NOVA1 to suppress proliferation, migration and invasion and promote apoptosis in astrocytoma

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Zhi, Feng ^a   Wang, Qiang ^a   Deng, Danni ^a   Shao, Naiyuan ^a   Wang, Rong ^a   Xue, Lian ^a   Wang, Suinuan ^a   Xia, Xiwei ^a   Yang, Yilin ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 181B 5P; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MIRN181 MICRORNA, HUMAN; NOVA1 PROTEIN, HUMAN; RNA BINDING PROTEIN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; ASTROCYTOMA; CANCER CELL; CANCER GROWTH; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; DOWN REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NOVA1 GENE; PATHOGENESIS; SURVIVAL RATE; TUMOR SUPPRESSOR GENE; UPREGULATION; BRAIN TUMOR; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR INVASION;

3' UNTRANSLATED REGIONS; APOPTOSIS; ASTROCYTOMA; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; RNA-BINDING PROTEINS;

EID: 84907763657     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0306667     Document Type: Erratum

References (31)

1. Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359: 492-507.
2. Gabayan AJ, Green SB, Sanan A, Jenrette J, Schultz C, et al. (2006) GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis. Neurosurgery 58: 701-709; discussion 701-709.
3. Esteller M (2011) Non-coding RNAs in human disease. Nat Rev Genet 12: 861-874.
4. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
5. Ryan BM, Robles AI, Harris CC (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10: 389-402.
6. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
7. Zhi F, Chen X, Wang S, Xia X, Shi Y, et al. (2010) The use of hsa-miR-21, hsamiR-181b and hsa-miR-106a as prognostic indicators of astrocytoma. Eur J Cancer 46: 1640-1649.
8. Shi ZM, Wang XF, Qian X, Tao T, Wang L, et al. (2013) MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas. RNA 19: 552-560.
9. Wang J, Sai K, Chen FR, Chen ZP (2013) miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1. Cancer Chemother Pharmacol 72: 147-158.
10. Zhi F, Zhou G, Shao N, Xia X, Shi Y, et al. (2013) miR-106a-5p Inhibits the Proliferation and Migration of Astrocytoma Cells and Promotes Apoptosis by Targeting FASTK. PLoS One 8: e72390.
11. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115: 787-798.
12. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nat Genet 37: 495-500.
13. John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al. (2004) Human MicroRNA targets. PLoS Biol 2: e363.
14. Zhi F, Gong G, Xu Y, Zhu Y, Hu D, et al. (2012) Activated beta-catenin Forces N2A Cell-derived Neurons Back to Tumor-like Neuroblasts and Positively Correlates with a Risk for Human Neuroblastoma. Int J Biol Sci 8: 289-297.
15. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
16. Chitwood DH, Timmermans MC (2010) Small RNAs are on the move. Nature 467: 415-419.
17. He L, Yao H, Fan LH, Liu L, Qiu S, et al. (2013) MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3. Genet Mol Res 12: 1012-1021.
18. Guo JX, Tao QS, Lou PR, Chen XC, Chen J, et al. (2012) miR-181b as a potential molecular target for anticancer therapy of gastric neoplasms. Asian Pac J Cancer Prev 13: 2263-2267.
19. Bisso A, Faleschini M, Zampa F, Capaci V, De Santa J, et al. (2013) Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer. Cell Cycle 12: 1679-1687.
20. Lu Y, Roy S, Nuovo G, Ramaswamy B, Miller T, et al. (2011) Anti-microRNA-222 (anti-miR-222) and-181B suppress growth of tamoxifen-resistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signal. J Biol Chem 286: 42292-42302.
21. Chen L, Yang Q, Kong WQ, Liu T, Liu M, et al. (2012) MicroRNA-181b targets cAMP responsive element binding protein 1 in gastric adenocarcinomas. IUBMB Life 64: 628-635.
22. Takiuchi D, Eguchi H, Nagano H, Iwagami Y, Tomimaru Y, et al. (2013) Involvement of microRNA-181b in the gemcitabine resistance of pancreatic cancer cells. Pancreatology 13: 517-523.
23. Cai B, An Y, Lv N, Chen J, Tu M, et al. (2013) miRNA-181b increases the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine in vitro and in nude mice by targeting BCL-2. Oncol Rep 29: 1769-1776.
24. Ratti A, Fallini C, Colombrita C, Pascale A, Laforenza U, et al. (2008) Posttranscriptional Regulation of Neuro-oncological Ventral Antigen 1 by the Neuronal RNA-binding Proteins ELAV. Journal of Biological Chemistry 283: 7531-7541.
25. Ule J, Stefani G, Mele A, Ruggiu M, Wang X, et al. (2006) An RNA map predicting Nova-dependent splicing regulation. Nature 444: 580-586.
26. Dredge BK, Stefani G, Engelhard CC, Darnell RB (2005) Nova autoregulation reveals dual functions in neuronal splicing. EMBO J 24: 1608-1620.
27. Park E, Iaccarino C, Lee J, Kwon I, Baik SM, et al. (2011) Regulatory roles of heterogeneous nuclear ribonucleoprotein M and Nova-1 protein in alternative splicing of dopamine D2 receptor pre-mRNA. J Biol Chem 286: 25301-25308.
28. Ruggiu M, Herbst R, Kim N, Jevsek M, Fak JJ, et al. (2009) Rescuing Z+ agrin splicing in Nova null mice restores synapse formation and unmasks a physiologic defect in motor neuron firing. Proceedings of the National Academy of Sciences 106: 3513-3518.
29. Li H, Sun C, Wang Y, Gao Y, Liu Y, et al. (2013) Dynamic expression pattern of neuro-oncological ventral antigen 1 (Nova1) in the rat brain after focal cerebral ischemia/reperfusion insults. J Histochem Cytochem 61: 45-54.
30. Zhang C, Frias MA, Mele A, Ruggiu M, Eom T, et al. (2010) Integrative modeling defines the Nova splicing-regulatory network and its combinatorial controls. Science 329: 439-443.
31. Ule J, Ule A, Spencer J, Williams A, Hu JS, et al. (2005) Nova regulates brainspecific splicing to shape the synapse. Nat Genet 37: 844-852.